ClinicalTrials.Veeva

Menu

Using a mHealth App to Improve Quality-of-Life Outcomes in Black Prostate Cancer Survivors

University of Oklahoma (OU) logo

University of Oklahoma (OU)

Status

Enrolling

Conditions

Prostate Cancer

Treatments

Behavioral: Surveys for Quality of Life
Behavioral: Surveys and mHealth App access

Study type

Interventional

Funder types

Other
Other U.S. Federal agency

Identifiers

NCT06651359
OU202403MA-MHEALTH
PC230551 (Other Grant/Funding Number)

Details and patient eligibility

About

The goal of this clinical trial is to ensure that the mobile health application for Black patients with prostate cancer (either actively undergoing treatment or survivors) is usable and acceptable to patients, get feedback about how to improve the app and assess its usefulness in examining their quality of life.

Full description

The purpose of this study is to test the effectiveness of a culturally appropriate and specific mobile app for ethnically diverse Black men with prostate cancer (either those actively undergoing treatment or survivors) to empower them to be active participants in their care. This app will provide 1) relevant information/education about prostate cancer-specific to Black men; 2) symptoms monitoring - allowing participants to report difficulties and prompting providers to respond to concerns; and 3) testimonials from other patients with shared experiences.

All participants will be asked to complete surveys online when they start and then again at 3, 6, 9, and 12 months. A subset of randomized participants will be provided access to this app, which they will be asked to use at home for 12 months. The app users will answer daily surveys about their symptoms and activities as well as weekly mood assessments for 3 months. At the end of the 12 months, interviews will be conducted to receive feedback regarding the app.

Enrollment

248 estimated patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

- Ethnically-diverse Black prostate cancer (CaP) survivors who are either native-born, Caribbean-born, or African-born, within the early phase of their CaP survivorship journey (defined as within the first five years after diagnosis).

Exclusion criteria

  • Men from other races.
  • Men who have never been diagnosed with CaP
  • Men who have the inability to speak English
  • Men who do not own a smartphone
  • Black CaP survivors who are over 5 years since the time of diagnosis

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

248 participants in 2 patient groups

Control group
Other group
Description:
Participants in this arm will be eligible Black men who have prostate cancer and are either currently undergoing treatment or are cancer survivors.
Treatment:
Behavioral: Surveys for Quality of Life
Intervention group
Experimental group
Description:
Participants in this arm will be eligible Black men who have prostate cancer and are either currently undergoing treatment or are cancer survivors, who are given access to the mHealth app for this study.
Treatment:
Behavioral: Surveys and mHealth App access
Behavioral: Surveys for Quality of Life

Trial contacts and locations

3

Loading...

Central trial contact

Motolani Adedipe, PhD, DPh, MS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems